Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2018.6847
Abstract: Key Points Question What are the morbidity and mortality of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) compared with other major oncologic surgical procedures? Findings In this cohort study of 1822 patients who received… read more here.
Keywords: risk; mortality; oncology; morbidity mortality ... See more keywords
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12930
Abstract: Key Points Question Can machine learning provide superior risk prediction compared with the current statistical methods for patients undergoing cytoreductive surgery? Findings In this prognostic study, an optimized machine learning model demonstrated superior capability of… read more here.
Keywords: learning model; machine; machine learning; risk ... See more keywords
Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2022.0143
Abstract: Key Points Question Does hyperthermic intraperitoneal chemotherapy (HIPEC) after primary or interval cytoreductive surgery increase survival in patients with ovarian cancer? Findings In this randomized clinical trial of 184 women with ovarian cancer, among those… read more here.
Keywords: surgery; survival; interval cytoreductive; ovarian cancer ... See more keywords
Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10774
Abstract: Although cytoreductive surgery has been shown to be beneficial in carefully selected patients with metastatic gastrointestinal stromal tumours (GISTs) treated with tyrosine kinase inhibitors (TKIs), factors predictive of postoperative morbidity have not been investigated previously. read more here.
Keywords: surgery; metastatic gastrointestinal; gastrointestinal stromal; cytoreductive surgery ... See more keywords
Postoperative complications affect long‐term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24632
Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.
Keywords: hyperthermic intraperitoneal; surgery hyperthermic; colorectal peritoneal; intraperitoneal chemotherapy ... See more keywords
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25939
Abstract: Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved… read more here.
Keywords: hyperthermic intraperitoneal; learning curve; intraperitoneal chemotherapy; curve ... See more keywords
Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26099
Abstract: Variations in care have been demonstrated both within and among institutions in many clinical settings. By standardizing perioperative practices, Enhanced Recovery After Surgery (ERAS) pathways reduce variation in perioperative care. We sought to characterize the… read more here.
Keywords: recovery; enhanced recovery; surgery; variation ... See more keywords
Feasibility and effectiveness of opioid-free anesthesia in cytoreductive surgery with or without heated intraperitoneal chemotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of surgical oncology"
DOI: 10.1002/jso.26833
Abstract: BACKGROUND Opioid-free anesthesia (OFA) provides analgesia minimizing opioids. OFA has not been evaluated in cytoreductive surgery (CRS) with or without heated intraperitoneal chemotherapy. We aim to evaluate OFA feasibility and effectiveness in CRS. METHODS Retrospective… read more here.
Keywords: opioid free; intraperitoneal chemotherapy; cytoreductive surgery; free anesthesia ... See more keywords
Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgery
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26969
Abstract: Failure to rescue (FTR) is defined as death after a major complication. We evaluated FTR after cytoreductive surgery (CRS) with and without hyperthermic intraperitoneal chemotherapy (HIPEC). read more here.
Keywords: intraperitoneal chemotherapy; major complication; hyperthermic intraperitoneal; failure rescue ... See more keywords
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27122
Abstract: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is an effective surgical intervention for peritoneal surface malignancy. The effect of myometrium invasion on outcomes is unknown. read more here.
Keywords: chemotherapy crs; surgery hyperthermic; intraperitoneal chemotherapy; hyperthermic intraperitoneal ... See more keywords
Quality and readability assessment of online patient information on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27143
Abstract: We aim to assess the quality and readability of online information available to patients considering cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC). read more here.
Keywords: quality readability; surgery hyperthermic; intraperitoneal chemotherapy; hyperthermic intraperitoneal ... See more keywords